Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Pancreatic and Bile Duct Cancer Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Sirnaomics
MacroGenics
Galera Therapeutics
Medivir
GlaxoSmithKline
RenovoRx
TransThera Biosciences
Taiho Oncology
RedHill Biopharma
Agios Pharmaceuticals
EMD Serono
Eisai
Senhwa Biosciences
By Type:
Vascular Endothelial Growth Factor Receptors
Others
Programmed Cell Death Protein
Signal Transducer Activator of Transcription
By Application:
Cholangiocarcinoma
Pancreatic Cancer
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Pancreatic and Bile Duct Cancer Drug Market Overview 2018-2029
-
1.1 China Pancreatic and Bile Duct Cancer Drug Industry Development Overview
-
1.2 China Pancreatic and Bile Duct Cancer Drug Industry Development History
-
1.3 China Pancreatic and Bile Duct Cancer Drug Industry Market Size (2018-2029)
-
1.4 China Pancreatic and Bile Duct Cancer Drug Market Analysis by Type from Production Side
-
1.4.1 China Pancreatic and Bile Duct Cancer Drug Production Volume, Production Value and Growth Rate of Vascular Endothelial Growth Factor Receptors (2018-2029)
-
1.4.2 China Pancreatic and Bile Duct Cancer Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.4.3 China Pancreatic and Bile Duct Cancer Drug Production Volume, Production Value and Growth Rate of Programmed Cell Death Protein (2018-2029)
-
1.4.4 China Pancreatic and Bile Duct Cancer Drug Production Volume, Production Value and Growth Rate of Signal Transducer Activator of Transcription (2018-2029)
-
1.5 China Pancreatic and Bile Duct Cancer Drug Market Analysis by Application from Consumption End
-
1.5.1 China Pancreatic and Bile Duct Cancer Drug Sales Volume, Sales Value and Growth Rate of Cholangiocarcinoma (2018-2029)
-
1.5.2 China Pancreatic and Bile Duct Cancer Drug Sales Volume, Sales Value and Growth Rate of Pancreatic Cancer (2018-2029)
-
1.6 China Pancreatic and Bile Duct Cancer Drug Market Analysis by Region
-
1.6.1 North China Pancreatic and Bile Duct Cancer Drug Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Pancreatic and Bile Duct Cancer Drug Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Pancreatic and Bile Duct Cancer Drug Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Pancreatic and Bile Duct Cancer Drug Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Pancreatic and Bile Duct Cancer Drug Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Pancreatic and Bile Duct Cancer Drug Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Pancreatic and Bile Duct Cancer Drug Market Size and Growth Rate from 2018-2029
Chapter 2 China Pancreatic and Bile Duct Cancer Drug Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Pancreatic and Bile Duct Cancer Drug Market Status and Competition at home and abroad in 2023
-
2.2.2 China Pancreatic and Bile Duct Cancer Drug Market Status and Competition Analysis in 2023
-
2.2.3 China Pancreatic and Bile Duct Cancer Drug Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Pancreatic and Bile Duct Cancer Drug Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Pancreatic and Bile Duct Cancer Drug Industry Development
Chapter 3 Pancreatic and Bile Duct Cancer DrugIndustry Chain Analysis
-
3.1 Pancreatic and Bile Duct Cancer Drug Industry Chain
-
3.2 Pancreatic and Bile Duct Cancer Drug Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Pancreatic and Bile Duct Cancer Drug Market
-
3.3 Pancreatic and Bile Duct Cancer Drug Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Pancreatic and Bile Duct Cancer Drug Market
Chapter 4 China Pancreatic and Bile Duct Cancer Drug Market, by Type
-
4.1 China Pancreatic and Bile Duct Cancer Drug Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Pancreatic and Bile Duct Cancer Drug Total Production Volume and Growth Rate from Production Side
-
4.5 China Pancreatic and Bile Duct Cancer Drug Production Volume and Growth Rate, by Type
-
4.5.1 China Pancreatic and Bile Duct Cancer Drug Production Volume and Growth Rate of Vascular Endothelial Growth Factor Receptors
-
4.5.2 China Pancreatic and Bile Duct Cancer Drug Production Volume and Growth Rate of Others
-
4.5.3 China Pancreatic and Bile Duct Cancer Drug Production Volume and Growth Rate of Programmed Cell Death Protein
-
4.5.4 China Pancreatic and Bile Duct Cancer Drug Production Volume and Growth Rate of Signal Transducer Activator of Transcription
Chapter 5 China Pancreatic and Bile Duct Cancer Drug Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Pancreatic and Bile Duct Cancer Drug Total Market Size and Growth Rate from Consumption End
-
5.5 China Pancreatic and Bile Duct Cancer Drug Market Size and Growth Rate, by Application
-
5.5.1 China Pancreatic and Bile Duct Cancer Drug Market Size and Growth Rate of Cholangiocarcinoma
-
5.5.2 China Pancreatic and Bile Duct Cancer Drug Market Size and Growth Rate of Pancreatic Cancer
Chapter 6 China Pancreatic and Bile Duct Cancer Drug Market, by Region
-
6.1 China Pancreatic and Bile Duct Cancer Drug Production Volume and Production Value, by Region
-
6.2 China Pancreatic and Bile Duct Cancer Drug Sales Volume and Sales Value, by Region
Chapter 7 North China Pancreatic and Bile Duct Cancer Drug Market Analysis
-
7.1 North China Pancreatic and Bile Duct Cancer Drug Market, by Type
-
7.2 North China Pancreatic and Bile Duct Cancer Drug Market, by Application
Chapter 8 Central China Pancreatic and Bile Duct Cancer Drug Market Analysis
-
8.1 Central China Pancreatic and Bile Duct Cancer Drug Market, by Type
-
8.2 Central China Pancreatic and Bile Duct Cancer Drug Market, by Application
Chapter 9 South China Pancreatic and Bile Duct Cancer Drug Market Analysis
-
9.1 South China Pancreatic and Bile Duct Cancer Drug Market, by Type
-
9.2 South China Pancreatic and Bile Duct Cancer Drug Market, by Application
Chapter 10 East China Pancreatic and Bile Duct Cancer Drug Market Analysis
-
10.1 East China Pancreatic and Bile Duct Cancer Drug Market, by Type
-
10.2 East China Pancreatic and Bile Duct Cancer Drug Market, by Application
Chapter 11 Northeast China Pancreatic and Bile Duct Cancer Drug Market Analysis
-
11.1 Northeast China Pancreatic and Bile Duct Cancer Drug Market, by Type
-
11.2 Northeast China Pancreatic and Bile Duct Cancer Drug Market, by Application
Chapter 12 Southwest China Pancreatic and Bile Duct Cancer Drug Market Analysis
-
12.1 Southwest China Pancreatic and Bile Duct Cancer Drug Market, by Type
-
12.2 Southwest China Pancreatic and Bile Duct Cancer Drug Market, by Application
Chapter 13 Northwest China Pancreatic and Bile Duct Cancer Drug Market Analysis
-
13.1 Northwest China Pancreatic and Bile Duct Cancer Drug Market, by Type
-
13.2 Northwest China Pancreatic and Bile Duct Cancer Drug Market, by Application
Chapter 14 Company Profiles
-
14.1 Sirnaomics
-
14.1.1 Sirnaomics Company Profile
-
14.1.2 Sirnaomics Pancreatic and Bile Duct Cancer Drug Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 MacroGenics
-
14.2.1 MacroGenics Company Profile
-
14.2.2 MacroGenics Pancreatic and Bile Duct Cancer Drug Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Galera Therapeutics
-
14.3.1 Galera Therapeutics Company Profile
-
14.3.2 Galera Therapeutics Pancreatic and Bile Duct Cancer Drug Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Medivir
-
14.4.1 Medivir Company Profile
-
14.4.2 Medivir Pancreatic and Bile Duct Cancer Drug Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 GlaxoSmithKline
-
14.5.1 GlaxoSmithKline Company Profile
-
14.5.2 GlaxoSmithKline Pancreatic and Bile Duct Cancer Drug Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 RenovoRx
-
14.6.1 RenovoRx Company Profile
-
14.6.2 RenovoRx Pancreatic and Bile Duct Cancer Drug Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 TransThera Biosciences
-
14.7.1 TransThera Biosciences Company Profile
-
14.7.2 TransThera Biosciences Pancreatic and Bile Duct Cancer Drug Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Taiho Oncology
-
14.8.1 Taiho Oncology Company Profile
-
14.8.2 Taiho Oncology Pancreatic and Bile Duct Cancer Drug Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 RedHill Biopharma
-
14.9.1 RedHill Biopharma Company Profile
-
14.9.2 RedHill Biopharma Pancreatic and Bile Duct Cancer Drug Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Agios Pharmaceuticals
-
14.10.1 Agios Pharmaceuticals Company Profile
-
14.10.2 Agios Pharmaceuticals Pancreatic and Bile Duct Cancer Drug Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 EMD Serono
-
14.11.1 EMD Serono Company Profile
-
14.11.2 EMD Serono Pancreatic and Bile Duct Cancer Drug Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Eisai
-
14.12.1 Eisai Company Profile
-
14.12.2 Eisai Pancreatic and Bile Duct Cancer Drug Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Senhwa Biosciences
-
14.13.1 Senhwa Biosciences Company Profile
-
14.13.2 Senhwa Biosciences Pancreatic and Bile Duct Cancer Drug Market Performance
-
14.13.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Pancreatic and Bile Duct Cancer Drug Industry Research Conclusions
-
15.2 Pancreatic and Bile Duct Cancer Drug Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Pancreatic and Bile Duct Cancer Drug Industry Market Size (2018-2029)
-
Figure China Pancreatic and Bile Duct Cancer Drug Production Volume, Production Value and Growth Rate of Vascular Endothelial Growth Factor Receptors (2018-2029)
-
Figure China Pancreatic and Bile Duct Cancer Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Pancreatic and Bile Duct Cancer Drug Production Volume, Production Value and Growth Rate of Programmed Cell Death Protein (2018-2029)
-
Figure China Pancreatic and Bile Duct Cancer Drug Production Volume, Production Value and Growth Rate of Signal Transducer Activator of Transcription (2018-2029)
-
Figure China Pancreatic and Bile Duct Cancer Drug Sales Volume, Sales Value and Growth Rate of Cholangiocarcinoma (2018-2029)
-
Figure China Pancreatic and Bile Duct Cancer Drug Sales Volume, Sales Value and Growth Rate of Pancreatic Cancer (2018-2029)
-
Figure North China Pancreatic and Bile Duct Cancer Drug Market Size and Growth Rate from 2018-2029
-
Figure Central China Pancreatic and Bile Duct Cancer Drug Market Size and Growth Rate from 2018-2029
-
Figure South China Pancreatic and Bile Duct Cancer Drug Market Size and Growth Rate from 2018-2029
-
Figure East China Pancreatic and Bile Duct Cancer Drug Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Pancreatic and Bile Duct Cancer Drug Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Pancreatic and Bile Duct Cancer Drug Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Pancreatic and Bile Duct Cancer Drug Market Size and Growth Rate from 2018-2029
-
Figure Pancreatic and Bile Duct Cancer Drug Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Pancreatic and Bile Duct Cancer Drug Market Share by Type in 2018
-
Figure China Pancreatic and Bile Duct Cancer Drug Market Share by Type in 2023
-
Figure China Pancreatic and Bile Duct Cancer Drug Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Pancreatic and Bile Duct Cancer Drug Production Volume and Growth Rate of Vascular Endothelial Growth Factor Receptors (2018-2023)
-
Figure China Pancreatic and Bile Duct Cancer Drug Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Pancreatic and Bile Duct Cancer Drug Production Volume and Growth Rate of Programmed Cell Death Protein (2018-2023)
-
Figure China Pancreatic and Bile Duct Cancer Drug Production Volume and Growth Rate of Signal Transducer Activator of Transcription (2018-2023)
-
Figure China Pancreatic and Bile Duct Cancer Drug Market Share by Application in 2018
-
Figure China Pancreatic and Bile Duct Cancer Drug Market Share by Application in 2023
-
Figure China Pancreatic and Bile Duct Cancer Drug Total Market Size and Growth Rate from Consumption End
-
Figure China Pancreatic and Bile Duct Cancer Drug Market Size and Growth Rate of Cholangiocarcinoma (2018-2023)
-
Figure China Pancreatic and Bile Duct Cancer Drug Market Size and Growth Rate of Pancreatic Cancer (2018-2023)
-
Table China Pancreatic and Bile Duct Cancer Drug Production Volume by Region (2018-2023)
-
Table China Pancreatic and Bile Duct Cancer Drug Production Volume Share by Region (2018-2023)
-
Figure China Pancreatic and Bile Duct Cancer Drug Production Volume Share by Region (2018-2023)
-
Table China Pancreatic and Bile Duct Cancer Drug Production Value by Region (2018-2023)
-
Table China Pancreatic and Bile Duct Cancer Drug Production Value Share by Region (2018-2023)
-
Figure China Pancreatic and Bile Duct Cancer Drug Production Value Share by Region (2018-2023)
-
Table China Pancreatic and Bile Duct Cancer Drug Sales Volume by Region (2018-2023)
-
Table China Pancreatic and Bile Duct Cancer Drug Sales Volume Share by Region (2018-2023)
-
Figure China Pancreatic and Bile Duct Cancer Drug Sales Volume Share by Region (2018-2023)
-
Table China Pancreatic and Bile Duct Cancer Drug Sales Value by Region (2018-2023)
-
Table China Pancreatic and Bile Duct Cancer Drug Sales Value Share by Region (2018-2023)
-
Figure China Pancreatic and Bile Duct Cancer Drug Sales Value Share by Region (2018-2023)
-
Table North China Pancreatic and Bile Duct Cancer Drug Production Volume by Type (2018-2023)
-
Table North China Pancreatic and Bile Duct Cancer Drug Production Volume Share by Type (2018-2023)
-
Figure North China Pancreatic and Bile Duct Cancer Drug Production Volume Share by Type (2018-2023)
-
Table North China Pancreatic and Bile Duct Cancer Drug Sales Volume by Application (2018-2023)
-
Table North China Pancreatic and Bile Duct Cancer Drug Sales Volume Share by Application (2018-2023)
-
Figure North China Pancreatic and Bile Duct Cancer Drug Sales Volume Share by Application (2018-2023)
-
Table Central China Pancreatic and Bile Duct Cancer Drug Production Volume by Type (2018-2023)
-
Table Central China Pancreatic and Bile Duct Cancer Drug Production Volume Share by Type (2018-2023)
-
Figure Central China Pancreatic and Bile Duct Cancer Drug Production Volume Share by Type (2018-2023)
-
Table Central China Pancreatic and Bile Duct Cancer Drug Sales Volume by Application (2018-2023)
-
Table Central China Pancreatic and Bile Duct Cancer Drug Sales Volume Share by Application (2018-2023)
-
Figure Central China Pancreatic and Bile Duct Cancer Drug Sales Volume Share by Application (2018-2023)
-
Table South China Pancreatic and Bile Duct Cancer Drug Production Volume by Type (2018-2023)
-
Table South China Pancreatic and Bile Duct Cancer Drug Production Volume Share by Type (2018-2023)
-
Figure South China Pancreatic and Bile Duct Cancer Drug Production Volume Share by Type (2018-2023)
-
Table South China Pancreatic and Bile Duct Cancer Drug Sales Volume by Application (2018-2023)
-
Table South China Pancreatic and Bile Duct Cancer Drug Sales Volume Share by Application (2018-2023)
-
Figure South China Pancreatic and Bile Duct Cancer Drug Sales Volume Share by Application (2018-2023)
-
Table East China Pancreatic and Bile Duct Cancer Drug Production Volume by Type (2018-2023)
-
Table East China Pancreatic and Bile Duct Cancer Drug Production Volume Share by Type (2018-2023)
-
Figure East China Pancreatic and Bile Duct Cancer Drug Production Volume Share by Type (2018-2023)
-
Table East China Pancreatic and Bile Duct Cancer Drug Sales Volume by Application (2018-2023)
-
Table East China Pancreatic and Bile Duct Cancer Drug Sales Volume Share by Application (2018-2023)
-
Figure East China Pancreatic and Bile Duct Cancer Drug Sales Volume Share by Application (2018-2023)
-
Table Northeast China Pancreatic and Bile Duct Cancer Drug Production Volume by Type (2018-2023)
-
Table Northeast China Pancreatic and Bile Duct Cancer Drug Production Volume Share by Type (2018-2023)
-
Figure Northeast China Pancreatic and Bile Duct Cancer Drug Production Volume Share by Type (2018-2023)
-
Table Northeast China Pancreatic and Bile Duct Cancer Drug Sales Volume by Application (2018-2023)
-
Table Northeast China Pancreatic and Bile Duct Cancer Drug Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Pancreatic and Bile Duct Cancer Drug Sales Volume Share by Application (2018-2023)
-
Table Southwest China Pancreatic and Bile Duct Cancer Drug Production Volume by Type (2018-2023)
-
Table Southwest China Pancreatic and Bile Duct Cancer Drug Production Volume Share by Type (2018-2023)
-
Figure Southwest China Pancreatic and Bile Duct Cancer Drug Production Volume Share by Type (2018-2023)
-
Table Southwest China Pancreatic and Bile Duct Cancer Drug Sales Volume by Application (2018-2023)
-
Table Southwest China Pancreatic and Bile Duct Cancer Drug Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Pancreatic and Bile Duct Cancer Drug Sales Volume Share by Application (2018-2023)
-
Table Northwest China Pancreatic and Bile Duct Cancer Drug Production Volume by Type (2018-2023)
-
Table Northwest China Pancreatic and Bile Duct Cancer Drug Production Volume Share by Type (2018-2023)
-
Figure Northwest China Pancreatic and Bile Duct Cancer Drug Production Volume Share by Type (2018-2023)
-
Table Northwest China Pancreatic and Bile Duct Cancer Drug Sales Volume by Application (2018-2023)
-
Table Northwest China Pancreatic and Bile Duct Cancer Drug Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Pancreatic and Bile Duct Cancer Drug Sales Volume Share by Application (2018-2023)
-
Table Sirnaomics Company Profile
-
Table Sirnaomics Pancreatic and Bile Duct Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table MacroGenics Company Profile
-
Table MacroGenics Pancreatic and Bile Duct Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table Galera Therapeutics Company Profile
-
Table Galera Therapeutics Pancreatic and Bile Duct Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table Medivir Company Profile
-
Table Medivir Pancreatic and Bile Duct Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table GlaxoSmithKline Company Profile
-
Table GlaxoSmithKline Pancreatic and Bile Duct Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table RenovoRx Company Profile
-
Table RenovoRx Pancreatic and Bile Duct Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table TransThera Biosciences Company Profile
-
Table TransThera Biosciences Pancreatic and Bile Duct Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table Taiho Oncology Company Profile
-
Table Taiho Oncology Pancreatic and Bile Duct Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table RedHill Biopharma Company Profile
-
Table RedHill Biopharma Pancreatic and Bile Duct Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table Agios Pharmaceuticals Company Profile
-
Table Agios Pharmaceuticals Pancreatic and Bile Duct Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table EMD Serono Company Profile
-
Table EMD Serono Pancreatic and Bile Duct Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table Eisai Company Profile
-
Table Eisai Pancreatic and Bile Duct Cancer Drug Revenue, Price and Gross (2018-2023)
-
Table Senhwa Biosciences Company Profile
-
Table Senhwa Biosciences Pancreatic and Bile Duct Cancer Drug Revenue, Price and Gross (2018-2023)
-
